Bab's Hobbs Pharma Guide

Tag: FDA

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025
Justine Traver

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025

iPLEDGE is the FDA's strict program to prevent birth defects from isotretinoin. Learn the 2025 requirements, recent changes, and how to navigate the system safely.

31 Dec 2025

Browse by category

  • Health & Wellness (199)

Latest news

  • Pirfenex (Pirfenidone) vs Other IPF Drugs: Comprehensive Comparison
  • Alcohol Binge Drinking on Warfarin: INR Swings and Bleeding Risk
  • Metallic Taste from Medications: Causes, Coping Strategies, and Relief
  • Bupropion vs Alternatives: Detailed Comparison of Benefits, Risks, and Effectiveness
  • Fildena Professional vs Other Sildenafil Options: A Detailed Comparison

Posts Tags

  • drug interactions
  • online pharmacy
  • medication safety
  • side effects
  • bioequivalence
  • medication reconciliation
  • online pharmacy safety
  • medication side effects
  • medication errors
  • patient safety
  • generic medication
  • Hatch-Waxman Act
  • generic drugs
  • narrow therapeutic index
  • medication adherence
  • dietary supplement
  • asthma treatment
  • patient communication
  • reemerging influenza
  • antihistamine side effects
Bab's Hobbs Pharma Guide
Menu
  • About
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact

© 2026. All rights reserved.